chr9-35042286-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000312292.6(C9orf131):c.32C>A(p.Ala11Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000706 in 1,614,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000312292.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C9orf131 | NM_203299.4 | c.32C>A | p.Ala11Asp | missense_variant | 1/2 | ENST00000312292.6 | NP_976044.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C9orf131 | ENST00000312292.6 | c.32C>A | p.Ala11Asp | missense_variant | 1/2 | 1 | NM_203299.4 | ENSP00000308279 | P2 | |
ENST00000624351.1 | n.2041G>T | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251244Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135804
GnomAD4 exome AF: 0.0000698 AC: 102AN: 1461850Hom.: 0 Cov.: 31 AF XY: 0.0000839 AC XY: 61AN XY: 727226
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.32C>A (p.A11D) alteration is located in exon 1 (coding exon 1) of the C9orf131 gene. This alteration results from a C to A substitution at nucleotide position 32, causing the alanine (A) at amino acid position 11 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at